No data available
Shionogi's policy is to strive constantly to provide medicine of the best possible kind essential for the protection of the health of the people. Our mission, based on this policy, is to deliver pharmaceuticals that offer the greatest possible level of satisfaction to patients, their families, and healthcare providers and that improve quality of life for patients and their families. To achieve the above goal, we are constantly engaged in research, development, manufacturing, and marketing activities, with a primary focus on prescription drugs.
No data available
Simbec Research has over 35 years' experience in clinical drug development, specialising in healthy and patient volunteer studies. Simbec's Phase I-IIa services include: first into man phase I studies, single and multi-dose tolerability; proof of concept phase IIa studies; drug-drug interaction studies; bioavailability/bioequivalence studies; mass balance/ADME/microdosing; genotyping/phenotyping; bioanalytical services (including assay development); central laboratory services; and QTc studies. Support services include: regulatory, protocol and report writing, medical writing, project management, and data management and statistics pharmacokinetics. Niche services include: ophthalmic research, gamma scintigraphy, dermatology and respiratory.
No data available
SIP Cambridge is a regional skills group driving a local approach to addressing skills challenges, growing the skills pipeline and developing specialist STEM provision.. . Members of the SIP in Cambridge gain direct insights into what others are doing and the benefits they are gaining from their approach to skills, as well as keeping up-to-date with skills funding and policy.
SK pharmteco is a global contract development and manufacturing organization (CDMO) serving the pharmaceutical and biopharmaceutical industries. With CGMP manufacturing sites, research and development facilities, and analytical laboratories across the United States, Europe, and South Korea, the company provides integrated services spanning Active Pharmaceutical Ingredients (APIs), advanced intermediates, registered starting materials, viral vectors for gene therapy, and analytical capabilities in support of client programs.
SK pharmteco partners with companies of all sizes to enable the development and delivery of transformative therapies worldwide. The company is a subsidiary of SK Inc. (KRX: 034730), the strategic investment arm of SK Group, South Korea’s second-largest conglomerate.
SK pharmteco partners with companies of all sizes to enable the development and delivery of transformative therapies worldwide. The company is a subsidiary of SK Inc. (KRX: 034730), the strategic investment arm of SK Group, South Korea’s second-largest conglomerate.
No data available
No data available
Making quality a way of life SPGL is a professional technical services company, built on highly skilled people and a deep passion for quality, excellence and exceptional service. Our sectors Bio-Pharmaceuticals Medical Devices & Diagnostics Regulated Consumer Products Chemicals Mission Critical Healthcare